Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 controls via the ENIGMA consortium
By T. V. van Erp, E. Walton, D. Hibar, L. Schmaal, Wenhao Jiang, David C. Glahn, Godfrey D. Pearlson, N. Yao, M. Fukunaga, R. Hashimoto and 168 more. Biological Psychiatry, 2018
815 citations recorded by the source corpus.
Background. The profile of cortical neuroanatomical abnormalities in schizophrenia is not fully understood, despite hundreds of published structural brain imaging studies. This study presents the first meta-analysis of cortical thickness and surface area abnormalities in schizophrenia conducted by the ENIGMA (Enhancing Neuro Imaging Genetics Through Meta Analysis) Schizophrenia Working Group. Method. The study included data from 4474 individuals with schizophrenia (mean age=32.3, range: 11–78; 66% male) and 5098 healthy volunteers (mean age=32.8, range: 10–87; 53% male), assessed with standardized methods, at 39 centers worldwide. Results. Compared to healthy volunteers, individuals with schizophrenia have widespread thinner cortex (left/right hemisphere: Cohen’s d=−0.530/−0.516) and smaller surface area (left/right hemisphere: d=−0.251/−0.254), with the largest effect sizes for both in frontal and temporal lobe regions. Regional group differences in cortical thickness remained significant when statistically controlling for global cortical thickness, suggesting regional specificity. In contrast, the effects for cortical surface area appear global. Case-control, negative, cortical thickness effect sizes were 2 to 3 times larger in antipsychotic medicated relative to unmedicated individuals. Negative correlations between age and bilateral temporal pole thickness were stronger in individuals with schizophrenia than in healthy volunteers. Regional cortical thickness showed significant negative correlations with normalized medication dose, symptom severity, and duration of illness, and positive correlations with age at onset. Conclusions. The findings indicate that the ENIGMA meta-analysis approach can achieve robust findings in clinical neuroscience studies; also, medication effects should be taken into account in future genetic association studies of cortical thickness in schizophrenia.
Subfields: Cognitive Neuroscience, Genetics, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/ec8a5d1502e46d8cf8b5c05a7fcc51594234837e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cognitive Neuroscience
In Psychiatry and Mental health
Citations in the corpus
- Cortico-cognition coupling in treatment resistant schizophrenia (2022, background): “They were recruited from the general community, and exclusion criteria included (1) previous or current history of psychiatric, neurological disorders or substance abuse or dependence, (2) prior or current use of antipsychotic medication, (3) premorbid IQ <70, (4) impaired thyroid function, or (5) h”